Muscle-specific inactivation of the IGF-I receptor induces compensatory hyperplasia in skeletal muscle
Year: 2002
Type: article
Abstract: During the development of skeletal muscle, myoblasts withdraw from the cell cycle and differentiate into myotubes.The insulin-like growth factors IGF-I and IGF-II, through their cognate tyrosine kinase receptor (IGF-I receptor), are known to play a role in this process.After withdrawal of myoblasts from the cell cycle, IGF-I promotes muscle differentiation by inducing the expression or activity of myogenic regulatory factors (MyoD, myogenin) and effectors (p21).However, little is known about the intracellular mechanisms by which the IGF-I system regulates these factors during the process of myogenesis.Here we show that MKR mice, which express a dominant negative IGF-I receptor specifically in skeletal muscle, have marked muscle hypoplasia from birth to 3 weeks of age.This hypoplasia occurs concomitantly with a decrease in ERK immunoreactivity levels and decreases in MyoD and myogenin expression.BrdU immunocytochemistry showed a compensatory hyperplasia as MKR mice grew to adulthood.Interestingly, hyperplasia occurred concomitantly with an increase in p38, MyoD, myogenin, and p21 immunoreactivity levels, as well as a decrease in Twist levels.These findings suggest that regulation of these cellular elements by IGF-I may play a role in the development and differentiation of skeletal muscle in vivo.
DOI: 10.1172/jci0213503
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W4254261608
